Singapore markets open in 5 hours 50 minutes

Bavarian Nordic A/S (BVNKF)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
22.600.00 (0.00%)
As of 09:34AM EDT. Market open.
Full screen
Trade prices are not sourced from all markets
Previous close22.60
Open22.60
Bid0.00 x 0
Ask0.00 x 0
Day's range22.60 - 22.60
52-week range17.45 - 32.05
Volume1
Avg. volume101
Market cap1.762B
Beta (5Y monthly)1.33
PE ratio (TTM)8.28
EPS (TTM)N/A
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
All
News
  • GlobeNewswire

    Resolutions of the Annual General Meeting 2024 of Bavarian Nordic A/S

    COPENHAGEN, Denmark, April 16, 2024 – Bavarian Nordic A/S (OMX: BAVA) today held the Annual General Meeting with the following results: The Annual Report for 2023 was adopted. The Board of Directors’ proposal to transfer the Company’s result to 2024 was also adopted.The Remuneration Report for 2023 was approved.The Board of Directors and the Board of Management were discharged from liability.Luc Debryune, Anders Gersel Pedersen, Frank Verwiel, Anne Louise Eberhard, Heidi Hunter and Johan van Hoo

  • GlobeNewswire

    Bavarian Nordic Announces Commercial Launch of Mpox Vaccine in the U.S.

    COPENHAGEN, Denmark, April 2, 2024 – Bavarian Nordic A/S (OMX: BAVA) announced today that JYNNEOS®, the only FDA-approved mpox vaccine, is now commercially available in the U.S., marking a significant expansion for access to JYNNEOS® by establishing additional pathways for vaccine procurement, distribution, and reimbursement by both public and private payers. Since 2022, in response to the global mpox outbreak, JYNNEOS has been made available through public health channels for individuals at ris

  • GlobeNewswire

    Bavarian Nordic A/S – Notice Convening Annual General Meeting

    COPENHAGEN, Denmark, March 21, 2024 – Pursuant to Articles 10-14 of the Articles of Association, the shareholders of Bavarian Nordic A/S are hereby convened to the Annual General Meeting to be held on Tuesday, 16 April 2024, at 4 PM CEST at Comwell Borupgaard, Nørrevej 80, DK-3070 Snekkersten, Denmark with the following agenda: The Board of Directors' report on the Company's activities in the past year.Presentation of the Annual Report for adoption.A proposal from the Board of Directors regardin